SCHEMBL7950642

SCHEMBL7950642

CCCc1nn(C)c2c(=O)[nH]c(-c3cc(CCCN)ccc3OCC)nc12

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.71
PDE5A O76074 18/20 0.69
PDE6C P51160 3/20 0.69
PDE1A P54750 2/20 0.69
PDE1B Q01064 2/20 0.69
PDE1C Q14123 2/20 0.69
MEN1 O00255 1/20 0.69
ALDH1A1 P00352 1/20 0.69
HPGD P15428 1/20 0.69
HDAC6 Q9UBN7 11/20 0.69
HDAC1 Q13547 10/20 0.68
HDAC2 Q92769 6/20 0.68
HDAC3 O15379 2/20 0.68
NCOR2 Q9Y618 2/20 0.68
KDM4E B2RXH2 1/20 0.66
PDE3A Q14432 3/20 0.64
PDE2A O00408 1/20 0.62
ABCC4 O15439 1/20 0.62
ABCC5 O15440 1/20 0.62
PDE6D O43924 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18715171 0.90 PDE5A (0.75) KMT2APDE5APDE6CPDE1APDE1B
SCHEMBL18715297 0.88 PDE5A (0.72) KMT2APDE5APDE6CPDE1APDE1B
SCHEMBL7959546 0.87 PDE5A (0.73) KMT2APDE5APDE6CPDE1APDE1B
SCHEMBL17404875 0.87 PDE5A (0.81) PDE5APDE6CHDAC6HDAC1HDAC2
SCHEMBL7950435 0.86 KMT2A (0.77) KMT2APDE5APDE6CPDE1APDE1B
SCHEMBL17390172 0.86 PDE5A (0.76) KMT2APDE5APDE6CPDE1APDE1B
SCHEMBL7950384 0.85 PDE5A (0.71) KMT2APDE5APDE6CPDE1APDE1B
SCHEMBL17390111 0.85 PDE5A (0.71) KMT2APDE5APDE6CPDE1APDE1B
SCHEMBL8803457 0.84 PDE5A (0.72) KMT2APDE5APDE6CPDE1APDE1B
SCHEMBL16003765 0.84 PDE5A (0.89) PDE5APDE6CHDAC6HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6200980-B1 ADMINISTERING PHENYL PURINONE COMPOUND FOR TREATING PRECANCEROUS LEISONS CELL PATHWAYS, INC. 2001-03-13 US disclosed
EP-0526004-B1 Pyrazolopyrimidinone antianginal agents PFIZER LTD (GB) 1997-10-08 EP disclosed
US-5426107-A Treatment of cardiovascular disorders, asthma, allergies PFIZER INC. (US) 1995-06-20 US disclosed
US-5272147-A Pyrazolopyrimidinone antianginal agents PFIZER INC. (US) 1993-12-21 US disclosed
EP-0526004-A1 Pyrazolopyrimidinone antianginal agents Pfizer Limited (GB) 1993-02-03 EP disclosed